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doi:10.1Objectives: To investigate the role of bronchoscopic intervention in the management of postoperative tracheo-
bronchial stenosis, a retrospective study was performed at a tertiary referral hospital.
Methods: Thirty patients who underwent 106 bronchoscopic interventions between January 2000 and July
2010, including ballooning, bouginage, Nd:YAG laser resection, and stent insertion, were included and followed
up for a median of 34 months.
Results: Silicone stents were required in 19 of 30 patients (63%) to maintain airway patency. Bronchoscopic
intervention provided improvement of dyspnea in 97% of the patients. After airway stabilization, the stents
were removed successfully in 7 of 19 patients (37%) a median of 7 months after insertion. In 3 patients
(10%), the intervention failed to widen the airway. There were no procedure-related deaths or cases of pneumo-
nia, although additional interventions were needed in 9 patients (30%) within 30 days. Stent-related late com-
plications (70%), such as restenosis (43%), overgrowth of granulation tissue (33%), stent migration (32%),
mucostasis (30%), and malacia after stent removal (16%), were controllable at follow-up bronchoscopy.
Conclusions: Bronchoscopic intervention could be a useful treatment modality for patients with postoperative
tracheobronchial stenosis when surgery is not feasible. (J Thorac Cardiovasc Surg 2012;144:217-22)Postoperative tracheobronchial stenosis (POTS) may result
from disruption of the vascular supply, tension of the anas-
tomotic site, or infection.1,2 Despite better understanding of
bronchial healing and the vascular supply of the
tracheobronchial tree, POTS still occurs in 1.8% to 8.7%
of patients and remains a serious complication of
tracheobronchial resection with or without end-to-end anas-
tomosis.3-5
The treatment of choice for benign tracheobronchial ste-
nosis is segmental resection of the stenosis site with end-to-
end anastomosis.6 Regardless of whether POTS occurs after
airway resection with or without lung parenchymal resec-
tion, however, most affected patients cannot undergo surgi-
cal correction because of low remaining lung function, poor
general condition, and technical difficulties. In these situa-
tions, bronchoscopic interventions, such as airway stenting,
ballooning, laser, and mechanical bouginage, may be
reasonable therapeutic modalities, along with the develop-
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The Journal of Thoracic and Careports on the efficacy or safety of bronchoscopic interven-
tions for POTS. This study therefore investigated the effi-
cacy and safety of interventional bronchoscopy for POTS.P
MMATERIALS AND METHODS
Study Population
The study was approved by the institutional review board of Samsung
Medical Center, a 1950-bed tertiary care general hospital in Seoul, Korea.
A retrospective review of medical records was performed for all patients
between January 2000 and July 2010 for whom all the following conditions
were met: (1) the patients underwent surgery; (2) airway stenosis devel-
oped postoperatively, as confirmed by chest radiography, computed tomog-
raphy, or bronchoscopy, (3) respiratory symptoms related to POTS, such as
dyspnea, cough, or chest pain, were present; and (4) bronchoscopic inter-
ventions were performed to widen the stenotic airway. In total, 35 patients
met these inclusion criteria. Patients were excluded if they had less than 2
months of follow-up or postprocedural information because of emergency
referral from another hospital. Ultimately, 30 patients were included.
The following data were investigated and analyzed: demographic char-
acteristics, underlying diseases, reason for surgery, type of surgery, pulmo-
nary function tests at baseline and after the procedure, interventional
bronchoscopic findings, methods of bronchoscopic intervention, clinical
outcome, and procedure-related complications.
Airway Intervention Techniques
The indications for bronchoscopic intervention in our institution were as
follows: (1) more than 50% stenosis in the trachea or complete or almost
complete atelectasis of 1 lung and (2) symptomatic dyspnea (greater than
American Thoracic Society grade 3), cough, or chest pain.
Airway anatomy and function were evaluated by chest radiography,
computed tomography, flexible bronchoscopy, and, if possible, spirometry.
Airway interventionwas performed according to the standard techniques of
Colt and Dumon8 and of Kim.9 After induction of general anesthesia, pa-
tients were intubated with a rigid bronchoscopic tube (Hopkins; Karl Storz
GmbH & Co, Tuttlingen, Germany). A flexible bronchoscope (EVIS BFrdiovascular Surgery c Volume 144, Number 1 217
TABLE 1. Baseline patient characteristics
Subjects 30
Male (no.) 16 (53%)
Age (y, median and range) 59 (9–74)
Reason for operation (no.)
Malignant neoplasm (no.) 15 (50%)
Malignant neoplasm of bronchus or lung 12 (40%)
Malignant neoplasm of trachea 3 (10%)
Postintubation tracheal stenosis 6 (20%)
Posttuberculosis tracheobronchial stenosis 3 (10%)
Trauma (traffic accident) 2 (7%)
Chemical intoxication 2 (7%)
Other (benign mass, ectopic thyroid mass) 2 (7%)
Type of operation (no.)
Tracheal resection and anastomosis 10 (33%)
Lobectomy 8 (27%)
Sleeve right upper lobectomy 6 (20%)
Carinal resection and reconstruction 2 (7%)
Other* 4 (13%)
Interval from surgery to interventional
bronchoscopy (d, median and range)
54 (4–481)
Baseline pulmonary function test results (n ¼ 13)
FEV1 percentage of predicted value
(median and range)
55% (25%–84%)
FVC percentage of predicted value
(median and range)
63% (43%–79%)
FEV1/FVC (median and range) 65 (33–87)
FEV1, Forced expiratory volume in 1 second; FVC, forced vital capacity. *End-to-end
anastomosis of left main bronchus; carinal resection and reconstruction with right up-
per lobectomy; resection of distal trachea, right main bronchus to distal bronchus in-
termedius, and right upper lobe bronchus, reconstruction of secondary carina, end-to
end-anastomosis between distal trachea and reconstructed bronchus; and left lower
lobectomy and end-to-end anastomosis of left main bronchus to left upper lobar
bronchus.
Abbreviations and Acronyms
FEV1 ¼ forced expiratory volume in 1 second
POTS ¼ postoperative tracheobronchial stenosis
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M1T240; Olympus Corporation, Tokyo, Japan) was then introduced through
the rigid bronchoscope, and the airway narrowing was evaluated.
For ballooning, a 10- or 12-mm controlled radial expansion balloon
(Boston Scientific Corporation, Natick, Mass) was inflated 2 or 3 times
to 3 atmospheres for 20 seconds. When localized dense fibrosis was ob-
served, an Nd:YAG laser (LaserSonics, Milpitas, Calif) was used to cut
the fibrotic bands with a G56D noncontact fiber (LaserSonics). Fibrotic ste-
noses were also gently dilated mechanically with a rigid bronchoscope
(bouginage), followed immediately by stent insertion.
Silicone stenting was indicated when (1) malacia of more than 180 of
the angle of the dilated lumen was observed, (2) the longitudinal stenotic
segment was longer than 2 cm, or (3) there was a third recurrence of airway
narrowing after ballooning. Airway stents were implanted according to the
standard technique described by Dumon.10 A stent of the appropriate size
was folded longitudinally, introduced into a stent pusher, and properly re-
positioned with alligator forceps.
After airway intervention, symptomatic reliefwas determined by a dysp-
nea scale survey administered on postprocedure day 1. Patients were usu-
ally discharged from the hospital 1 to 3 days after the procedure and were
followed up 1, 3, 6, 9, and 12 months after the procedure with chest radi-
ography and spirometry. Bronchoscopy and chest computed tomography
were performed when needed to reassess the stent position and effective-
ness. Stent removal was planned once the patients had been in stable con-
dition for longer than 6 months.
Stents
In this study, the types of stents used were the Natural stent (M1S Co,
Seoul, Korea), the Dumon stent (BryanCorp, Woburn, Mass), the Y-stent
(BryanCorp), and the Montgomery T-tube (Koken, Tokyo, Japan). No
metal stents were used.11
The Natural stent is a silicone stent developed at the Samsung Medical
Center in 2002. Studies in a canine model of tracheal stenosis and clinical
experience in patients with benign tracheobronchial stenosis have shown
that the Natural stent is as effective and safe as the Dumon stent.12,13
Either the Dumon or Natural stent was selected according to the
availability and bronchoscopist’s preference.
The Y-stent is a Y-shaped silicone stent designed for stenoses of the tra-
chea, both bronchi, and the carina. TheMontgomery T-tubewas used in pa-
tients with upper tracheal stenosis, usually after a postoperative
tracheostomy.14
Statistical Analysis
Continuous variables are expressed as the median and range, and cate-
goric variables are expressed as numbers with percentages. To assess the
effectiveness of bronchoscopic interventions according to objective data,
the forced expiratory volume in 1 second (FEV1) values before and after
bronchoscopic interventions were compared with the Wilcoxon signed-
rank test. The survival curve of patients was calculated with the Kaplan-
Meier method. All statistical tests were 2-tailed, and P values<.05 were
considered to indicate statistical significance.RESULTS
Baseline Patient Characteristics
The baseline characteristics of the study populations are
summarized in Table 1. Malignant neoplasms (50%) were218 The Journal of Thoracic and Cardiovascular Surgthe most common reason for surgery, and the most common
operation was tracheal resection and anastomosis (33%).
The interval from surgery to interventional bronchoscopy
was a median of 54 days (range, 4–481 days). Before inter-
ventional bronchoscopy, baseline pulmonary function tests
were conducted in 13 of 30 patients (43%). Their percent-
age of predicted FEV1 was 55% (range, 25%–84%).
Bronchoscopic Findings and Interventions
The bronchoscopic findings and interventions are sum-
marized in Table 2. The types of stenosis could be classified
as fibrous stricture, overgrowth of granulation tissue, and
malacia.
The most common method of airway intervention was
stent insertion, which was performed in 19 of 30 patients
(63%). There were a total of 50 stents placed (33 Natural
stents, 13 Y-stents, 3 Dumon stents, and 1 Montgomery
T-tube), and a median of 2 (range, 1–15) stents per patient
were used. The interventions usually involved a combina-
tion of modalities, however, such as ballooning, bouginage
(mechanical dilatation with rigid tubes), and Nd:YAG laser
cauterization. In total, 106 interventional bronchoscopic
procedures were performed in the 30 patients. A medianery c July 2012
TABLE 2. Bronchoscopic findings and interventions (n ¼ 30)
No. %
Stenosis site
Trachea 10 33%
Bronchus intermedius 8 27%
One main bronchus 7 23%
Both main bronchi 2 7%
Carina 2 7%
Left lower lobar bronchus 1 3%
Stenosis type
Overgrowth of granulation tissue 16 53%
Fibrous stricture 12 40%
Malacia 2 7%
Method of airway dilatation (overlapping data)
Stent insertion 19 63%
Bouginage 18 60%
Ballooning 17 57%
Nd:YAG laser 11 37%
TABLE 3. Outcomes and complications of bronchoscopic
interventions in 30 patients with postoperative tracheobronchial
stenosis
Improvement of dyspnea (no.) 29 (97%)
Successful single intervention (no.) 17 (57%)
Average time before second intervention
(d, n ¼ 13)
79.5
Stent insertion (no.) 19 (63%)
Successful stent removal (no.) 7
Duration of stent placement
(mo, median and range)
7 (1–22)
Duration of follow-up after stent removal
(mo, median and range)
57 (13–74)
Persistent stent placement (no.) 12
Duration of stent placement
(mo, median and range)
16 (2–101)
FEV1 percentage of predicted
(median and range, n ¼ 9)
Before interventions 51% (25%–65%)
After interventions 61% (22%–84%)
Change after interventions (%)* 22% (31% to 200%)
30-d complications (no.) 9 (30%)
30-d mortality 0
Intervention-related pneumonia 0
Need for repeated intervention within 30 d 9 (30%)
Intubation within<2 d 2 (7%)
Stent migration within 30 d (n ¼ 19) 2 (11%)
Late complications (no, multiples counted) 21 (70%)
Restenosis 13 (43%)
Overgrowth of granulation tissue 10 (33%)
Mucostasis 9 (30%)
Stent migration (n ¼ 19) 6 (32%)
Malacia after stent removal (n ¼ 19) 3 (16%)
Jeong et al Perioperative Managementof 2.5 bronchoscopic interventions (range, 1–23 interven-
tions) were performed per patient during a median follow-
up period of 34 months. Among the 30 patients, 17 patients
underwent a single intervention successfully. Thirteen pa-
tients underwent a second intervention an average of 79.5
days after the first intervention. Three patients underwent
intervention more than 5 times (8, 10, and 23 times). The
patient who required 23 interventions was followed up for
103 months after the carinal resection and reconstruction
because of adenoid cystic carcinoma. Another 2 patients
had undergone extensive resection and anastomosis for
posttuberculosis tracheobronchial stenosis.FEV1, Forced expiratory volume in 1 second. *Change calculated as follows: (base-
line value – value after intervention)/baseline value 3 100%; P ¼ .038.
P
MOutcomes and Complications
The overall clinical outcomes are summarized in Table 3
and Figure 1. Improvement of dyspnea was achieved 1 day
after the first intervention in 29 of 30 patients (97%). Be-
cause many patients were unable to complete spirometry
because of their severe dyspnea and poor general condition,
9 patients underwent pulmonary function testing both be-
fore and after the procedures. In these patients, the percent-
age of predicted FEV1 was improved significantly, by 22%
(31% to 200%) relative to baseline values.
Overall 19 (63%) patients were treated with stents; stents
were inserted during the initial bronchoscopic intervention
in 14 patients and during the follow-up interventions in 5
patients. In 7 of 19 patients, the stent could be removed.
The median duration of stent placement in these patients
was 7 months (1–22 months), and the duration of follow-
up after stent removal was 57 months (13–74 months). In
1 of these 7 patients, we failed to widen the stricture of
the right bronchus intermedius that occurred after a sleeve
right upper lobectomy performed to treat lung cancer.
In the remaining 12 patients, the stent was not removed.
In 8 patients, there were extensive losses of cartilage andThe Journal of Thoracic and Capersistent malacia after endobronchial tuberculosis
(n ¼ 4), radiation therapy (n ¼ 2), or chemical burn
(n ¼ 2). The remaining 2 patients refused removal
(n ¼ 2). The median duration of stent placement in these
12 patients was 16 months (2–101 months).
During the entire follow-up period, 11 (37%) patients
underwent bronchoscopic intervention without stenting.
Among these patients, 1 patient underwent pneumonec-
tomy because of massive hemoptysis and suspected reste-
nosis because of the sequelae of pulmonary tuberculosis,
unrelated to the interventional bronchoscopic procedure.
In another patient, we failed to widen the stenosis of the
right main bronchus that occurred after a sleeve right upper
lobectomy for lung cancer.
Overall, 3 of 30 patients (10%) in whom bronchoscopic
intervention failed could not undergo any surgical correc-
tion because of low remaining lung function, poor general
condition, and technical difficulties. In 2 of these 3 cases,
we referred patients back to their hometown hospitals
with supportive care after follow-up durations of 3.3 andrdiovascular Surgery c Volume 144, Number 1 219
FIGURE 1. The overall clinical outcomes of interventional bronchoscopy in patients with postoperative tracheobronchial stenosis.
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M11.4 months from the last intervention. The other patient
died of cancer progression after a follow-up duration of
18.2 months from the last intervention.
Overall complications are shown in Table 3. Minor com-
plications, such as pain and fever, were relatively common,
but there were no cases of procedure-related pneumonia or
death.Within 30 days after the procedure, repeated interven-
tion was needed in 9 patients (30%), including endotracheal
intubation within less than 2 days in 2 patients (7%) andFIGURE 2. Survival curves after first bronchoscopic intervention of patients wi
disease, and for malignant disease. No significant difference could be seen betw
and that associated with malignant disease by log-rank test (P ¼ .121). The su
intervention were 89% and 82%, respectively.
220 The Journal of Thoracic and Cardiovascular Surgstent repositioning as a result of migration in 2 patients
(11%). Stent-related late complications were common
(70%). Restenosis developed in 13 patients (43%), granula-
tion tissue formed at the site of the procedure in 10 patients
(33%), mucostasis necessitated bronchoscopic toilet in 9 pa-
tients (30%), stent migration occurred in 6 patients (32%),
and malacia of the trachea or bronchus after stent removal
developed in 3 patients (16%). Repeated bronchoscopic in-
terventions were needed to treat these complications.th postoperative tracheobronchial stenosis (POTS) for all causes, for benign
een postoperative tracheobronchial stenosis associated with benign disease
rvivals among patients with POTS of all causes at 3 and 5 years after first
ery c July 2012
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MDisease Course and Survival
During follow-up, 5 patients died within a median of 50
months (20–79 months). The cause of death was not related
to POTS or interventional bronchoscopy in any cases.
Causes of death were cancer progression (n¼ 2), acute leu-
kemia (n¼ 1), H1N1 influenza–related pneumonia (n¼ 1),
and massive hemoptysis (n¼ 1). The survival probabilities,
as evaluated with the Kaplan-Meier method, are shown in
Figure 2. The probability of being alive at 3 years after
the first interventional bronchoscopy was 89%; the proba-
bility at 5 years was 82%.
DISCUSSION
In this study, immediate improvement of dyspnea was
achieved in 97% of the patients after interventional bron-
choscopy. Objectively, the percentage of predicted FEV1
also increased significantly, by 22% (31% to 200%) after
the intervention. These positive results are consistent with
the results obtained with other causes of benign tracheo-
bronchial stenosis.15-20 Five patients died during the
follow-up period, but no deaths was associated with
POTS or interventional bronchoscopy. It was very encour-
aging that only 3 of these 30 nonsurgical patients had failure
of bronchoscopic intervention and that there were no
procedure-related deaths.
Most patients (70%) did have late complications, such as
restenosis (43%), granulation formation (33%), mucostasis
(30%), stent migration (32%), and malacia after stent re-
moval (16%). These rates are consistent with studies of pa-
tients with benign tracheobronchial stenosis other than
POTS.13,15,16,21 Even with this high incidence of late
complications, repeated bronchoscopic interventions
could control most of the complications except in 3 cases.
Patients undergoing bronchoscopic intervention do require
close monitoring, because the initial procedure is often
not durable and a third of patients will require repeated
interventions throughout their course.
Malacia after stent removal occurred in 3 of 19 patients
with stenting (16%); this has not been reported in studies
of benign tracheobronchial stenosis with other causes,
such as postuberculosis and postintubation stenosis. We
suggest that the malacia resulted from excessive tension af-
ter agonistic anastomosis, decreased vascularity of the
bronchial wall, and continued inflammation caused by su-
ture material, followed by broad, transmural injuries of
the bronchial wall. In these 3 cases, the stents could not
be removed within 7, 25, and 78 months after the malacia
developed. The stent may have caused damage to the airway
wall, leading to malacia, especially in patients who received
a stent but did not have malacia in the first place.
Our experience included 8 patients with POTS after sim-
ple lobectomy. Seven of the 8 patients had calcified lymph
nodes near the lobectomy stump before the surgery. Al-
though there was no evidence of reactivation of tuberculosisThe Journal of Thoracic and Cain these patients, the cause of calcified lymph nodes is likely
related, because tuberculosis was highly prevalent in South
Korea 20 years ago. It might be postulated that POTS could
be a result of the adjacent calcified lymph nodes and asso-
ciated chronic granulomatous inflammation.
This study has several limitations. First, it was a retro-
spective study of a heterogeneous patient population with
various interventions and outcomes; thus, the objective
data to prove clinical efficacy are lacking. The reason for
this lack of objective data is that the patients were critically
ill at the time of intervention. Although interventions were
usually performed in a critical situation, we used accepted
methods and guidelines of bronchoscopic intervention.
Postprocedure efficacy was therefore determined during
the same hospitalization, rather than through longer term
follow-up. Second, this case series was small; however,
this is only the first study to evaluate the results of POTS sta-
tistically. Third, some outcomes were measured by subjec-
tive methods. For example, symptomatic relief was
determined by a dyspnea scale survey. Finally, because
this study was performed in a single institution in Korea, se-
lection bias is probable. Ten of 30 patients (33%) were re-
ferred from other hospitals, so it is impossible to investigate
the exact total number of patients with airway complica-
tions after the surgery.
In conclusion, interventional bronchoscopy appears to be
an alternative treatment modality for patients with POTS in
whom surgery is not feasible. Further clinical studies should
follow.
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